26 results on '"Wu, Zhaozhen"'
Search Results
2. The efficacy and safety of chemotherapy with or without anti‐PD‐1 for the first‐line treatment of advanced urothelial carcinoma
3. Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma
4. Research on Lightweight Human Pose Estimation Model Based on Knowledge Distillation
5. Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
6. Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
7. Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
8. Comparative effectiveness of pembrolizumab vs. nivolumab in patients with recurrent or advanced NSCLC
9. Multi-tasking for Aspect-based Sentiment Analysis via Constructing Auxiliary Self-Supervision ACOP task
10. Hydroxyl and amino functionalized cyclometalated Ir(III) complexes: Synthesis, characterization and cytotoxicity studies
11. The gut microbiota modulates responses to anti–PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors
12. Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
13. The Synergistic Effect of PARP Inhibitors and Immune Checkpoint Inhibitors
14. Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors
15. Anti-PD-1/L1 plus anti-angiogenesis therapy as second-line or later treatment in advanced lung adenocarcinoma
16. PLEKHM2-ALK: A novel fusion in small-cell lung cancer and durable response to ALK inhibitors
17. Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer
18. Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting.
19. A retrospective cohort study of anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer.
20. Methylglyoxal: A newly detected and potentially harmful metabolite in the blood of ketotic dairy cows
21. Downregulation of MCT 4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma
22. Inhibition of Methylglyoxal-Induced Histone H1 Nε-Carboxymethyllysine Formation by (+)-Catechin
23. Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.
24. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism
25. The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility.
26. Inhibition of Methylglyoxal-Induced Histone H1 N ε -Carboxymethyllysine Formation by (+)-Catechin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.